Both in Pharmaceuticals
Enliven Therapeutics vs Organon &
Over the past year ELVN returned +148.6% and OGN returned +112.1%; their daily moves had a correlation of 0.09.
ELVN +148.6% OGN +112.1%Growth of $1, one year, split-adjusted
| Metric | ELVN | OGN |
|---|---|---|
| Price | $47.25 | $13.83 |
| Market cap | $3.46B | $3.63B |
| Today | +5.40% | −0.14% |
| 1 month | +11.5% | +0.7% |
| 6 months | +14.7% | +3.1% |
| Year to date | +206.8% | +92.9% |
| 1 year | +136.3% | +106.1% |
| Revenue growth (YoY) | — | −1.7% |
| Gross margin | — | 55.2% |
| Net margin | — | 10.4% |
| P/E (TTM) | — | 17.1× |
| Price / sales | — | 0.6× |
| Net cash | $895.2M | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 41.7% | 2.9% |
| Short % of float | 16.4% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).